Safety and preliminary clinical activity of ropotrectinib ( TPX-0005), a ROS1/TRK/ALK inhibitor, in advanced ROS1 fusion-positive NSCLC Meeting Abstract
| Authors: | Lin, J.; Kim, D.; Drilon, A.; Doebele, R.; Lee, J.; Zhu, V.; Ahn, M.; Lim, J.; Stopatschinskaja, S.; Cui, J. J.; Hyman, D.; Camidge, R.; Ou, S.; Shaw, A.; Cho, B. C. |
| Abstract Title: | Safety and preliminary clinical activity of ropotrectinib ( TPX-0005), a ROS1/TRK/ALK inhibitor, in advanced ROS1 fusion-positive NSCLC |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | ros1; tpx-0005; g2032r |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S322 |
| Language: | English |
| ACCESSION: | WOS:000454014500224 |
| DOI: | 10.1016/j.jtho.2018.08.240 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OA02.02 -- Source: Wos |
